Real World Study on Erlotinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Condition:   Efficacy and Safety of Erlotinib Combined With Bevacizumab in EGFR Mutation Positive Advanced Non-squamous Non-small Cell Lung Cancer Intervention:   Drug: erlotinib combined with Bevacizumab Sponsor:   Hunan Province Tumor Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials